SCHEMBL2201035

SCHEMBL2201035

Cc1c(O)ccc(C(C)(C)c2ccccc2)c1C(C)(C)c1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 6/20 0.46
ESR2 Q92731 5/20 0.46
ALDH1A1 P00352 4/20 0.46
CYP3A4 P08684 2/20 0.46
CNR1 P21554 4/20 0.40
CNR2 P34972 4/20 0.40
TRPA1 O75762 1/20 0.36
ATM Q13315 1/20 0.36
TSHR P16473 2/20 0.35
TDP1 Q9NUW8 1/20 0.35
ALOX15 P16050 1/20 0.34
AR P10275 1/20 0.33
HPGD P15428 1/20 0.33
SLC6A2 P23975 1/20 0.33
SLC6A4 P31645 1/20 0.33
HTR6 P50406 1/20 0.33
ESRRG P62508 1/20 0.33
SLC6A3 Q01959 1/20 0.33
HSD17B10 Q99714 1/20 0.33
MAPT P10636 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27866164 0.85 ESR1 (0.48) ESR1ESR2ALDH1A1CYP3A4CNR1
SCHEMBL983909 0.85 ESR1 (0.48) ESR1ESR2ALDH1A1CYP3A4CNR1
SCHEMBL983778 0.81 CNR1 (0.45) ESR1ESR2ALDH1A1CYP3A4CNR1
SCHEMBL9774408 0.78 ESR1 (0.58) ESR1ESR2ALDH1A1CYP3A4CNR1
SCHEMBL2204310 0.78 ESR1 (0.42) ESR1ESR2ALDH1A1CYP3A4CNR1
SCHEMBL982955 0.78 ESR1 (0.48) ESR1ESR2ALDH1A1CYP3A4CNR1
SCHEMBL2202727 0.77 ESR2 (0.38) ESR1ESR2ALDH1A1CYP3A4CNR1
SCHEMBL980178 0.76 ESR1 (0.49) ESR1ESR2ALDH1A1CYP3A4CNR1
SCHEMBL7711319 0.76 ESR1 (0.47) ESR1ESR2ALDH1A1CYP3A4CNR1
Toluene SCHEMBL27928703 0.76 CNR1 (0.48) ESR1ESR2ALDH1A1CYP3A4CNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2792673-B1 Carbamic acid ester derivatives for the production of isocyanate and aromatic hydroxy compounds ASAHI CHEMICAL IND (JP) 2018-07-25 EP disclosed
CN-103467730-B Carbamate compounds Asahi Kasei Chemical K. K. (JP) 2015-12-23 CN disclosed
EP-2213658-B1 METHOD FOR PRODUCTION OF ISOCYANATE AND AROMATIC HYDROXY COMPOUND ASAHI KASEI CHEMICALS CORP (JP) 2015-09-09 EP disclosed
EP-2792673-A1 Carbamic acid ester derivatives for the production of isocyanate and aromatic hydroxy compounds Asahi Kasei Chemicals Corporation (JP) 2014-10-22 EP disclosed
CN-101868445-B Method for producing isocyanate and aromatic hydroxy compound ASAHI CHEMICAL CORP 2014-06-18 CN disclosed
CN-101652344-B Method for production of isocyanate using composition comprising carbamic acid ester and aromatic hydroxy compound, and composition for transport or storage of carbamic acid ester ASAHI CHEMICAL CORP JP 2014-06-04 CN disclosed
US-8703989-B2 Isocyanates and aromatic hydroxy compounds ASAHI KASEI CHEMICALS CORPORATION (JP) 2014-04-22 US disclosed
CN-102026965-B Method for producing isocyanate ASAHI KASEI CHEMICALS CORP 2014-02-26 CN disclosed
CN-103467730-A Carbamate compound ASAHI KASEI CHEMICAL CORP 2013-12-25 CN disclosed
US-20130178643-A1 Isocyanates and Aromatic Hydroxy Compounds ASAHI KASEI CHEMICAL CORPORATION (JP) 2013-07-11 US disclosed
US-8293934-B2 Isocyanates and aromatic hydroxy compounds ASAHI KASEI CHEMICALS CORPORATION (JP) 2012-10-23 US disclosed
US-20110319648-A1 Isocyanates and Aromatic Hydroxy Compounds SHINOHATA MASAAKI (JP) 2011-12-29 US disclosed
US-7977504-B2 Process for producing isocyanates and aromatic hydroxy compounds ASAHI KASEI CHEMICALS CORPORATION (JP) 2011-07-12 US disclosed
US-20100274047-A1 PROCESS FOR PRODUCING OF ISOCYANATES AND AROMATIC HYDROXY COMPOUNDS ASAHI KASEI CHEMICALS CORPORATION (JP) 2010-10-28 US disclosed
EP-2213658-A1 METHOD FOR PRODUCTION OF ISOCYANATE AND AROMATIC HYDROXY COMPOUND Asahi Kasei Chemicals Corporation (JP) 2010-08-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110319648-A1 Isocyanates and Aromatic Hydroxy Compounds PAH, APEH, HPD ESR1 818/4885ESR2 1554/4885ALDH1A1 2817/4885
US-20130178643-A1 Isocyanates and Aromatic Hydroxy Compounds PAH, APEH, HPD ESR1 818/4885ESR2 1554/4885ALDH1A1 2817/4885
US-20100274047-A1 PROCESS FOR PRODUCING OF ISOCYANATES AND AROMATIC HYDROXY COMPOUNDS PAH, APEH, HPD ESR1 1124/4885ESR2 1539/4885ALDH1A1 2913/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.